157 related articles for article (PubMed ID: 38235361)
21. Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.
Song G; Zhang F; Tian C; Gao X; Zhu X; Fan D; Tian Y
Nucleic Acids Res; 2022 Mar; 50(5):2836-2853. PubMed ID: 35188577
[TBL] [Abstract][Full Text] [Related]
22. Strong and tunable anti-CRISPR/Cas activities in plants.
Calvache C; Vazquez-Vilar M; Selma S; Uranga M; Fernández-Del-Carmen A; Daròs JA; Orzáez D
Plant Biotechnol J; 2022 Feb; 20(2):399-408. PubMed ID: 34632687
[TBL] [Abstract][Full Text] [Related]
23. Corrigendum: Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
Microbiology (Reading); 2018 Jul; 164(7):1004. PubMed ID: 29813017
[No Abstract] [Full Text] [Related]
24. Rapid characterization of anti-CRISPR proteins and optogenetically engineered variants using a versatile plasmid interference system.
Song G; Tian C; Li J; Zhang F; Peng Y; Gao X; Tian Y
Nucleic Acids Res; 2023 Dec; 51(22):12381-12396. PubMed ID: 37930830
[TBL] [Abstract][Full Text] [Related]
25. RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.
Sundaresan R; Parameshwaran HP; Yogesha SD; Keilbarth MW; Rajan R
Cell Rep; 2017 Dec; 21(13):3728-3739. PubMed ID: 29281823
[TBL] [Abstract][Full Text] [Related]
26. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
27. Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in
Jiang YH; Liu YF; Wang K; Zhou JY; Guo F; Zhao QW; Mao XM
ACS Synth Biol; 2021 Nov; 10(11):2833-2841. PubMed ID: 34734710
[TBL] [Abstract][Full Text] [Related]
28. Anti-CRISPR Protein AcrIIC5 Inhibits CRISPR-Cas9 by Occupying the Target DNA Binding Pocket.
Hwang S; Shah M; Garcia B; Hashem N; Davidson AR; Moraes TF; Maxwell KL
J Mol Biol; 2023 Apr; 435(7):167991. PubMed ID: 36736884
[TBL] [Abstract][Full Text] [Related]
29. Conformational control of DNA target cleavage by CRISPR-Cas9.
Sternberg SH; LaFrance B; Kaplan M; Doudna JA
Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
[TBL] [Abstract][Full Text] [Related]
30. Protein-Mutation-Induced Conformational Changes of the DNA and Nuclease Domain in CRISPR/Cas9 Systems by Molecular Dynamics Simulations.
Ray A; Di Felice R
J Phys Chem B; 2020 Mar; 124(11):2168-2179. PubMed ID: 32079396
[TBL] [Abstract][Full Text] [Related]
31. NmeCas9 is an intrinsically high-fidelity genome-editing platform.
Amrani N; Gao XD; Liu P; Edraki A; Mir A; Ibraheim R; Gupta A; Sasaki KE; Wu T; Donohoue PD; Settle AH; Lied AM; McGovern K; Fuller CK; Cameron P; Fazzio TG; Zhu LJ; Wolfe SA; Sontheimer EJ
Genome Biol; 2018 Dec; 19(1):214. PubMed ID: 30518407
[TBL] [Abstract][Full Text] [Related]
32. Atomic-scale insights into allosteric inhibition and evolutional rescue mechanism of
Li X; Wang C; Peng T; Chai Z; Ni D; Liu Y; Zhang J; Chen T; Lu S
Comput Struct Biotechnol J; 2021; 19():6108-6124. PubMed ID: 34900128
[TBL] [Abstract][Full Text] [Related]
33. DNA rehybridization drives product release from Cas9 ribonucleoprotein to enable multiple-turnover cleavage.
Pan J; Mabuchi M; Robb GB
Nucleic Acids Res; 2023 May; 51(8):3903-3917. PubMed ID: 37014013
[TBL] [Abstract][Full Text] [Related]
34. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
[TBL] [Abstract][Full Text] [Related]
35. Leveraging QM/MM and Molecular Dynamics Simulations to Decipher the Reaction Mechanism of the Cas9 HNH Domain to Investigate Off-Target Effects.
Maghsoud Y; Jayasinghe-Arachchige VM; Kumari P; Cisneros GA; Liu J
J Chem Inf Model; 2023 Nov; 63(21):6834-6850. PubMed ID: 37877218
[TBL] [Abstract][Full Text] [Related]
36. Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome.
Forsberg KJ; Bhatt IV; Schmidtke DT; Javanmardi K; Dillard KE; Stoddard BL; Finkelstein IJ; Kaiser BK; Malik HS
Elife; 2019 Sep; 8():. PubMed ID: 31502535
[TBL] [Abstract][Full Text] [Related]
37. Structural insights into DNA cleavage activation of CRISPR-Cas9 system.
Huai C; Li G; Yao R; Zhang Y; Cao M; Kong L; Jia C; Yuan H; Chen H; Lu D; Huang Q
Nat Commun; 2017 Nov; 8(1):1375. PubMed ID: 29123204
[TBL] [Abstract][Full Text] [Related]
38. Nucleolus localization of SpyCas9 affects its stability and interferes with host protein translation in mammalian cells.
Tan R; Du W; Liu Y; Cong X; Bai M; Jiang C; Li Z; Tan M; Ma DK; Huang Q; Jiang W; Dang Y
Genes Dis; 2022 May; 9(3):731-740. PubMed ID: 35782966
[TBL] [Abstract][Full Text] [Related]
39. Orthogonal CRISPR-Cas tools for genome editing, inhibition, and CRISPR recording in zebrafish embryos.
Takasugi PR; Wang S; Truong KT; Drage EP; Kanishka SN; Higbee MA; Bamidele N; Ojelabi O; Sontheimer EJ; Gagnon JA
Genetics; 2022 Jan; 220(1):. PubMed ID: 34735006
[TBL] [Abstract][Full Text] [Related]
40. AcrIIA5 Suppresses Base Editors and Reduces Their Off-Target Effects.
Liang M; Sui T; Liu Z; Chen M; Liu H; Shan H; Lai L; Li Z
Cells; 2020 Jul; 9(8):. PubMed ID: 32727031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
